NetVRk launches SilkAI, an AI system for its metaverse platform. It aims to enhance virtual environments with lifelike ...

Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission ...

Fortive Corp (NYSE: FTV) reports disappointing Q4 revenues. Analysts maintain mixed outlook with price targets ranging from ...

Elanco Animal Health's ELAN short percent of float has risen 9.53% since its last report. The company recently reported that ...

Cleveland-Cliffs is making a move higher due to the news concerning tariffs. After a long downtrend, a bull market may be ...

Incyte says 2025 is expected to be a year of defining catalysts with four launches, four pivotal study readouts, at least ...

BNB's (CRYPTO: BNB) price has fallen 3.15% to $602.38. This is opposite to its positive trend over the past week where it has ...

Global Payments GPN has outperformed the market over the past 20 years by 2.28% on an annualized basis producing an average ...

ON Semiconductor Corp (ON) stock reported a fiscal Q4 2024 revenue decline of 15% YoY to $1.72B, missing analysts' estimate ...

According to Benzinga Pro, CVS Health's peer group average for short interest as a percentage of float is 10.10%, which means ...

Axsome settles Auvelity patent litigation with Teva, delaying a generic launch until 2038. Analysts see growth potential with Symbravo's migraine approval.

Roivant Sciences ROIV reported its Q3 earnings results on Monday, February 10, 2025 at 07:00 AM. Here's what investors need ...